CVS Health (CVS) Tops Q2 EPS by 36c, Raises FY EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Stocks fall as higher oil prices, Treasury yields weigh
- S&P 500 breadth hits lowest level since dot-com bubble, Goldman says
- Nvidia’s AI dominance funds historic $150 billion buyback
- MongoDB stock drops 15% as CEO Desai resigns for Meta
- Jefferies cuts Roblox to Underperform, says rally is too optimistic
CVS Health (CVS) PT Raised to $95 at Cantor Fitzgerald
August 4, 2021 12:48 PM EDTCantor Fitzgerald analyst Steven Halper raised the price target on CVS Health (NYSE: CVS) to $95.00 (from $92.00) while maintaining a Overweight rating following earnings.
The analyst commented, ". We reiterate our Overweight rating on CVS shares and increase our price target to $95 from $92. Before the market open on Wednesday, August... More
